CBRS shares sink 12% after Q2 as muted Q3 growth and margin pressure overshadow surging revenues, while its $25.4B RPO supports long-term growth.
Cerebras' (CBRS) Q2 earnings outperformance and recent AMD Helios collaboration has materially weakened by previous sell thesis by improving WSE's opportunity within disaggregated inference architectures. OpenAI's GPT-5.6 Sol Ultrafast preview released this morning (August 14) also provides further validation of Cerebras' differentiated low-latency inference advantage. While I was wrong to underappreciate WSE's competitiveness alongside emerging rack-scale platforms, meaningful third-party penetration remains unproven - despite robust AI capex spending commitments.
Cerebras's missed Wall Street's sales and earnings targets for the second quarter. Despite the Q2 misses, the company delivered significant upward revisions to its full-year targets.
Cerebras Systems beats Q2 estimates as core revenues jump 103%, fueled by a 287% surge in cloud services and rapid adoption of fast inference.
The Department of Labor reported that the producer price index (PPI) for final products remained unchanged in July. The Zacks Consensus Estimate was for an increase of 0.1%.
Cerebras shares are sinking, despite solid results from the chipmaker in the second quarter since it went public earlier this year.
Cerebras Systems Inc (NASDAQ:CBRS) shares fell 11% Thursday after the AI chipmaker reported second-quarter revenue below Wall Street estimates, even as the company raised its full-year guidance. The company posted second-quarter revenue of $180.1 million, missing the $194 million analyst estimate, though up 74% year-over-year.
CBRS is building data-center and manufacturing capacity to support 2027 growth as fast-inference demand strengthens and 2026 revenue guidance rises.
Shares of Cerebras Systems (Nasdaq: CBRS) are down more than 17% in premarket trading this morning.
Cerebras Systems is well-positioned for a shift toward smaller, faster AI models that prioritize inference speed and memory efficiency over sheer model size. CBRS's architectural advantages, such as wafer-scale chips and reduced reliance on constrained supply chains, support its ability to meet rising demand for agentic inference. Raised FY guidance, strong Q2 core revenue growth (+103% YoY), and expanding cloud/inference ecosystem underpin a bullish outlook despite premium valuation and customer concentration risks.
Shares of Cerebras Systems Inc (NASDAQ:CBRS) are down 15.9% at $220.31 before the open, despite the AI chipmaker reporting a narrower-than-expected second-quarter loss of 5 cents per share and raising its full-year guidance, as revenue of $180 million missed estimates of $194 million.
Cerebras Systems stock (NASDAQ: CBRS) whipsawed on Wednesday after investors cheered the Nvidia challenger before earnings, then punished it once the numbers arrived. The stock jumped 11.6% during the regular session to $262.06, only to fall about 18% in extended trading.